Nektar Therapeutics
NKTR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000906709
In the last 90 days, Nektar Therapeutics insiders filed 0 open-market purchases and 2 sales; 239 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Nektar Therapeutics changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 217 | 1 | 197 | −19 |
| Shares | 168.9M | 110.5K | 172.7M | +3.89M (+2.3%) |
| Value | $381.7M | $275.0K | $121.2M | −$260.3M (−68.2%) |
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Nektar Therapeutics at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Deep Track Capital, LP | 1,743,248 | $1.23M | 0.05% |
| OrbiMed Advisors LLC | 1,034,059 | $726.8K | 0.01% |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 288,634 | $202.9K | 0.00% |
| Caption Management, LLC | 175,411 | $123.3K | 0.03% |
| Walleye Trading LLC | 83,063 | $58.4K | 0.00% |
| Marshall Wace, LLP | 53,900 | $37.7K | 0.00% |
| US Asset Management LLC | 37,964 | $27.0K | 0.03% |
| Jump Financial, LLC | 19,800 | $13.9K | 0.00% |
| Captrust Financial Advisors | 19,191 | $13.5K | 0.00% |
| Liberty Wealth Management LLC | 19,000 | $13.4K | 0.00% |
| Maltin Wealth Management, Inc. | 13,000 | $9.14K | 0.01% |
| Flagship Harbor Advisors, LLC | 10,550 | $7.42K | 0.00% |
| Baader Bank INC | 10,723 | $5.88K | 0.00% |
| Red Tortoise LLC | 942 | $662 | 0.00% |
| WealthPlan Investment Management, LLC | 660 | $462 | 0.00% |
| Dark Forest Capital Management LP | 429 | $302 | 0.00% |
| Strategic Investment Solutions, Inc. | 200 | $141 | 0.00% |
| Baystate Wealth Management LLC | 100 | $70 | 0.00% |
| Global Retirement Partners, LLC | 16 | $13 | 0.00% |
| Toronto Dominion Bank | 9 | $0 | 0.00% |
Sold out (39)
Institutions that held Nektar Therapeutics at the end of Q4 2022 and filed for Q1 2023 without it.
Not filed for Q1 2023 yet (1)
Institutions that held Nektar Therapeutics at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Comerica Bank | 110,531 | $275.0K |